Malaria cases in Switzerland from 2005 to 2015 and recent rise of imported Plasmodium vivax malaria

Reporting cases of malaria to the Federal Office of Public Health has been mandatory in Switzerland since 1974. We analysed notifications of imported confirmed malaria cases between 2005 and 2015 in Switzerland or Liechtenstein. Data for previously visited countries, nationality and reason for tra...

Full description

Bibliographic Details
Main Authors: Gilles Eperon, Sophie Durieux-Paillard, Anne Mauris, François Chappuis, Nicole Gysin
Format: Article
Language:English
Published: SMW supporting association (Trägerverein Swiss Medical Weekly SMW) 2017-10-01
Series:Swiss Medical Weekly
Subjects:
Online Access:https://www.smw.ch/index.php/smw/article/view/2376
_version_ 1811289207069474816
author Gilles Eperon
Sophie Durieux-Paillard
Anne Mauris
François Chappuis
Nicole Gysin
author_facet Gilles Eperon
Sophie Durieux-Paillard
Anne Mauris
François Chappuis
Nicole Gysin
author_sort Gilles Eperon
collection DOAJ
description Reporting cases of malaria to the Federal Office of Public Health has been mandatory in Switzerland since 1974. We analysed notifications of imported confirmed malaria cases between 2005 and 2015 in Switzerland or Liechtenstein. Data for previously visited countries, nationality and reason for travelling were analysed. In contrast with the impressive drop of malaria cases reported worldwide since 2000, we found that the number of malaria cases imported yearly in Switzerland doubled in 2014 and 2015 compared to the average for the preceding decade. Since 2014, Plasmodium vivax infection represented 36% of all diagnosed malaria cases in Switzerland, compared to 11% in the decade leading to 2013. Most of the vivax malaria patients originated from the Horn of Africa, especially from Eritrea. This rise in cases was a consequence not only of an increase in the number of Eritrean refugees, but also their vivax malaria incidence rate, which jumped from 1–3‰ previously to 12‰ in 2014. This is a trend that is not matched by national statistics in Eritrea. An unreported increased incidence in the country of origin (Eritrea) might be the cause of the rise of Pv cases imported into Switzerland, but infections are also likely to occur along the harsh and long migration journey. This epidemiology highlights the need to register and use primaquine for the treatment of latent-phase P. vivax malaria in Switzerland, a medicine currently neither marketed nor systematically reimbursed. Moreover, general practitioners should be aware of this specific epidemiological situation in order to avoid misdiagnosis of febrile Eritreans even months after they reach Switzerland.
first_indexed 2024-04-13T03:50:50Z
format Article
id doaj.art-125bd10979e0439c9263f8747234d187
institution Directory Open Access Journal
issn 1424-3997
language English
last_indexed 2024-04-13T03:50:50Z
publishDate 2017-10-01
publisher SMW supporting association (Trägerverein Swiss Medical Weekly SMW)
record_format Article
series Swiss Medical Weekly
spelling doaj.art-125bd10979e0439c9263f8747234d1872022-12-22T03:03:50ZengSMW supporting association (Trägerverein Swiss Medical Weekly SMW)Swiss Medical Weekly1424-39972017-10-01147414210.4414/smw.2017.14510Malaria cases in Switzerland from 2005 to 2015 and recent rise of imported Plasmodium vivax malariaGilles Eperon0Sophie Durieux-Paillard1Anne Mauris2François Chappuis3Nicole Gysin4Division of Tropical and Humanitarian Medicine, Department of Community Medicine, Primary and Emergency Care, Geneva University Hospitals (HUG), SwitzerlandMigrant Health Programme, Department of Community Medicine, Primary and Emergency Care, Geneva University Hospitals (HUG), SwitzerlandDepartment of Genetics and Laboratory Medicine, Geneva University Hospitals (HUG), Geneva, SwitzerlandDivision of Tropical and Humanitarian Medicine, Department of Community Medicine, Primary and Emergency Care, Geneva University Hospitals (HUG), SwitzerlandCommunicable Disease Division, Federal Office of Public Health (FOPH), Bern, Switzerland Reporting cases of malaria to the Federal Office of Public Health has been mandatory in Switzerland since 1974. We analysed notifications of imported confirmed malaria cases between 2005 and 2015 in Switzerland or Liechtenstein. Data for previously visited countries, nationality and reason for travelling were analysed. In contrast with the impressive drop of malaria cases reported worldwide since 2000, we found that the number of malaria cases imported yearly in Switzerland doubled in 2014 and 2015 compared to the average for the preceding decade. Since 2014, Plasmodium vivax infection represented 36% of all diagnosed malaria cases in Switzerland, compared to 11% in the decade leading to 2013. Most of the vivax malaria patients originated from the Horn of Africa, especially from Eritrea. This rise in cases was a consequence not only of an increase in the number of Eritrean refugees, but also their vivax malaria incidence rate, which jumped from 1–3‰ previously to 12‰ in 2014. This is a trend that is not matched by national statistics in Eritrea. An unreported increased incidence in the country of origin (Eritrea) might be the cause of the rise of Pv cases imported into Switzerland, but infections are also likely to occur along the harsh and long migration journey. This epidemiology highlights the need to register and use primaquine for the treatment of latent-phase P. vivax malaria in Switzerland, a medicine currently neither marketed nor systematically reimbursed. Moreover, general practitioners should be aware of this specific epidemiological situation in order to avoid misdiagnosis of febrile Eritreans even months after they reach Switzerland. https://www.smw.ch/index.php/smw/article/view/2376Plasmodium vivax
spellingShingle Gilles Eperon
Sophie Durieux-Paillard
Anne Mauris
François Chappuis
Nicole Gysin
Malaria cases in Switzerland from 2005 to 2015 and recent rise of imported Plasmodium vivax malaria
Swiss Medical Weekly
Plasmodium vivax
title Malaria cases in Switzerland from 2005 to 2015 and recent rise of imported Plasmodium vivax malaria
title_full Malaria cases in Switzerland from 2005 to 2015 and recent rise of imported Plasmodium vivax malaria
title_fullStr Malaria cases in Switzerland from 2005 to 2015 and recent rise of imported Plasmodium vivax malaria
title_full_unstemmed Malaria cases in Switzerland from 2005 to 2015 and recent rise of imported Plasmodium vivax malaria
title_short Malaria cases in Switzerland from 2005 to 2015 and recent rise of imported Plasmodium vivax malaria
title_sort malaria cases in switzerland from 2005 to 2015 and recent rise of imported plasmodium vivax malaria
topic Plasmodium vivax
url https://www.smw.ch/index.php/smw/article/view/2376
work_keys_str_mv AT gilleseperon malariacasesinswitzerlandfrom2005to2015andrecentriseofimportedplasmodiumvivaxmalaria
AT sophiedurieuxpaillard malariacasesinswitzerlandfrom2005to2015andrecentriseofimportedplasmodiumvivaxmalaria
AT annemauris malariacasesinswitzerlandfrom2005to2015andrecentriseofimportedplasmodiumvivaxmalaria
AT francoischappuis malariacasesinswitzerlandfrom2005to2015andrecentriseofimportedplasmodiumvivaxmalaria
AT nicolegysin malariacasesinswitzerlandfrom2005to2015andrecentriseofimportedplasmodiumvivaxmalaria